Volume : 09, Issue : 10, October – 2022



Authors :

Neha Fathima*, Dr. Jyothi P, Dr. R. Hemalatha

Abstract :

The coordinate compression approach, which has been around for a long time, benefits quickly dissolving definitions significantly. Furthermore, various concentrations of the super disintegrant were used to provide the most bioavailable information possible. In definitions with a predominant super disintegrant, in vitro crumbling time and disintegration will be accelerated, while friability and weight change will be reduced. When super disintegrants are used to create a fast-dissolving tablet, it is faster and releases the pharmaceutical sooner than a conventionally developed tablet. A cumulative rate of Headache medicine tablets with varying concentrations of CCS and Maize Starch were discovered to have been freed from the definition over time.
In this study, F7’s solvency clearly outperforms F1, F2, F3, F4, F5, and F6. Aspirin quick dissolving tablets can be successfully manufactured, and it is anticipated that the availability of a wide range of mechanical alternatives and a few advantages will lead to an increase in quiet compliance and its notoriety in the near future.
Keywords: super disintegrant, solvency, dissolving tablets

Cite This Article:

Please cite this article in Neha Fathima et al Formulation And Evaluation Of Controlled Release Of Aspirin Tablet Using Direct Compression Method, Indo Am. J. P. Sci, 2022; 09(10).

Number of Downloads : 10


1. Sastry.S.V., Nyshadham.J.R. and Fix.J.A. Recent technological advances in oral Drug delivery – a review. Pharm Sci Technol Today, 3, 2000; pp. 138–145.
2. Rathbone.M.J., Hadgraft.J. and Roberts.M.S. Modified release drug delivery technology. Marcel Dekker, 2003; New York.
3. Lordi.N.G. Sustained release dosage forms. In: Lachman, L., Lieberman, The theory and practice of industrial pharmacy, 3rd edn. Varghese Publishing House, Bombay, 1987; pp.430– 456.
4. Chiao.C.S.L. and Robinson.J.R. Sustained release drug delivery systems. Remington: the science and practice of pharmacy, vol. II. Mack Publishing Company, Easton, PA, pp. 1995; 1660–1675.
5. Kydonieus.A.F. Fundamental concepts of controlled release. In: Controlled release technologies: Methods, theory, and applications. vol. I. CRC, Florida, 1990; pp. 1–19.
6. Lordi N.G. “Sustained release dosage form” chapter 14 in “Theory and practice of Industrial Pharmacy” , 3rd edition, Varghese Publishing House, 1991;p. 430-431.
7. Welling.P.G., Dobrinska.M.R. Chapter 6 in “Controlled drug delivery: Fundamentals and applications”, 2nd edition, Marcel Dekker Inc., Volume 29, 1978: pp.254-289.
8. Madhukat, Mansukalal.D, Milind, Dattatraya Joshi and Bharat Pravinchandra. M. Pharmaceutical composition for controlled drug delivery system, patent No: US 7,157,100 B2, ; 2007.
9. James Swarbrick, James C. Boylan. Encyclopedia of Pharmaceutical Technology.2007; pp. 369-394.
10. Venkataraman Daar.S N, Chester.A, Kliener.L. An overview of Controlled release systems, Handbook of Pharmaceutical Controlled release technology, Marcel dekker Inc: 2000; p p.1-30.
11. Gilberts, Banker, Neil R. Anderson, Sustained release dosage forms; The Theory and Practice of Industrial Pharmacy, 2001; 3rd edition.pp.430- 456.
12. Rudnic E. and Schawartz J.B, Oral solid dosage forms, Remington’s Pharmaceutical Sciences, Mack Publishing Company, Easton, Pennsylvania,1965; pp. 2000.
13. Ahmad, A. B., Bennett, P. N. & Rowland, M. Influence of route of hepatic administration on drug availability. Journal of Pharmacology and Experimental Therapeutics 230, 1984; pp.718—725.
14. Joseph Robinson. R, Vincent H. L. Lee, Controlled drug delivery fundamentals and applications, Marcel Dekker Inc, New York:3- 61.2002.
15. Birkett.D.J. Half-life, Pharmacokinetics made easy, Australian prescriber, 11: 1996; p.57-59.
16. Hogan, J.E. Hydroxypropylmethylcellulose sustained release technology. Drug Dev Ind Pharm, 1989; pp. 975–999.
17. Velasco.M.V., Ford. J.L., Rowe.P. and Rajabi-Siahboomi, A.R. Influence of drug: HPMC ratio, drug and Polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release, 1999; 57, pp. 75–85.
18. Mitchell. K., Ford, J.L., Armstrong, D.J., Elliott, P.N., Hogan, J.E. and Rostron, C. The influence of drugs on the properties of gels and swelling characteristics of matrices Containing methylcellulose or hydroxypropylmethylcellulose. Int J Pharm, 1993; pp.165–17.
19. Ford.J.L., Rubinstein.M.H., Changela.A. and Hogan.J.E. The influence of pH on the dissolution of promethazine hydrochloride from hpmc controlled release tablets. J Pharm. Pharmacol, 1985; 37, pp.115-119.
20. Levina.M., Gothoskar.A. and Rajabi Siahboomi.A. Application of a Modeling system in the formulation of extended-release hydrophilic matrices. Pharm Technol Eur, 2006; 18, pp.20–26.